ICOS and cancer: In contrast, other genes that encode immune stimulators, such as CD28, CD80, ICOS, CD40LG, CD27, CD48, IL6, IL2RA, LTA, MICB, and KLRC1 generally showed a negative correlation with PEBP1/STK11 co-expression across most cancer types.